Citadel Advisors
MESO

Citadel Advisors’s Mesoblast MESO Stock Holding History

Citadel Advisors’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
82,900
+41,800
+102% +$621K ﹤0.01% 7927
2026
Q1 		$632K Buy
41,100
+10,000
+32% +$167K ﹤0.01% 8725
2025
Q4 		$561K Sell
31,100
-35,000
-53% -$602K ﹤0.01% 8751
2025
Q3 		$1.06M Buy
66,100
+2,700
+4% +$39.5K ﹤0.01% 7404
2025
Q2 		$690K Sell
63,400
-19,300
-23% -$216K ﹤0.01% 7871
2025
Q1 		$1.03M Sell
82,700
-33,950
-29% -$559K ﹤0.01% 6880
2024
Q4 		$2.31M Buy
116,650
+64,750
+125% +$717K ﹤0.01% 5332
2024
Q3 		$424K Sell
51,900
-1,600
-3% -$10.9K ﹤0.01% 8612
2024
Q2 		$364K Buy
53,500
+29,200
+120% +$200K ﹤0.01% 8719
2024
Q1 		$122K Buy
24,300
+15,850
+188% +$33.8K ﹤0.01% 11086
2023
Q4 		$18.6K Sell
8,450
-1,750
-17% -$4.17K ﹤0.01% 12683
2023
Q3 		$25.1K Sell
10,200
-11,600
-53% -$55.4K ﹤0.01% 12431
2023
Q2 		$170K Sell
21,800
-12,300
-36% -$87.9K ﹤0.01% 10132
2023
Q1 		$224K Buy
34,100
+23,800
+231% +$158K ﹤0.01% 9976
2022
Q4 		$59.9K Sell
10,300
-1,350
-12% -$8.44K ﹤0.01% 11913
2022
Q3 		$59K Sell
11,650
-7,850
-40% -$47.4K ﹤0.01% 11514
2022
Q2 		$87K Buy
19,500
+14,250
+271% +$98.1K ﹤0.01% 11532
2022
Q1 		$44K Sell
5,250
-600
-10% -$5.1K ﹤0.01% 12882
2021
Q4 		$56K Sell
5,850
-10,650
-65% -$124K ﹤0.01% 13184
2021
Q3 		$198K Sell
16,500
-12,000
-42% -$167K ﹤0.01% 11993
2021
Q2 		$426K Buy
28,500
+12,250
+75% +$192K ﹤0.01% 10417
2021
Q1 		$269K Sell
16,250
-20,200
-55% -$382K ﹤0.01% 11091
2020
Q4 		$619K Sell
36,450
-17,050
-32% -$420K ﹤0.01% 7751
2020
Q3 		$1.99M Buy
53,500
+21,000
+65% +$658K ﹤0.01% 4729
2020
Q2 		$740K Buy
+32,500
New +$696K ﹤0.01% 6377

Other funds holding MESO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
FFA
Fi3 Financial Advisors Indianapolis, Indiana $418M AUM 35.26% 1-Year Est. Return

Citadel Advisors's MESO Position: Q2 2026 in Review

Citadel Advisors sold out of Mesoblast (MESO) in Q2 2026, closing a stake of 85,959 shares — an estimated $1.28M sold.

Citadel Advisors first reported a position in MESO in Q3 2018 and held it in 19 quarters. The position peaked at $6.08M in Q1 2025. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • Citadel Advisors reported no remaining Mesoblast position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 85,959 Mesoblast shares in Q2 2026, an estimated $1.28M.
  • Citadel Advisors first reported a position in Mesoblast in Q3 2018 and held it in 19 quarters.
  • Citadel Advisors's Mesoblast position peaked at $6.08M in Q1 2025.
  • 72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.